Roche to present new data in multiple sclerosis and neuromyelitis optica spectrum disorder at MSVirtual2020
The Pharma Data
SEPTEMBER 2, 2020
Other data to be presented will show high treatment persistence and strong adherence for patients treated with OCREVUS compared to other DMTs in real-world settings. A full list of Roche presentations can be found at: [link]. Presentations at MSVirtual2020: 8th Joint ACTRIMS-ECTRIMS Meeting include: Medicine. Abstract Title.
Let's personalize your content